Med-IQ CLL: A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
Study Details
Study Description
Brief Summary
This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
This multifaceted initiative will include evaluating patient perspectives on their QoL, evaluating provider perspectives on managing QoL, and providing education to the whole CLL care team (hematologists/oncologists, nurse practitioners, physician assistants, and nurses) on contemporary approaches for individualized, patient-centered management of CLL. Providers, including physicians, nurse practitioners, and physician assistants will participate in educational initiatives geared towards enhancing their knowledge and confidence with managing QoL concerns for patients with CLL. Pre and post surveys will be conducted with providers to evaluate change in these areas. The project aims to train this team on how to enhance communication with patients and caregivers as a means to increase patient engagement in care and QoL in this population.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Clinician education
|
Other: Education Intervention
Education interventions will be delivered sporadically within the 6-month window between the time the clinician completes the pre-survey and when he/she completes the post-survey. Interventions consist of e-brief publications, teleconferences with project faculty, and evidence based resources.
|
Outcome Measures
Primary Outcome Measures
- Change in provider knowledge with management of Quality of Life Concerns for CLL patients, as measured by survey [Baseline, 6 months]
- Change in provider confidence with management of Quality of Life Concerns for CLL patients, as measured by survey [Baseline, 6 months]
Eligibility Criteria
Criteria
Inclusion Criteria: Clinician
-
Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network
-
Participant treats patients with CLL
-
Participant is willing to participate in the educational component of this project
Inclusion Criteria: Patient
-
Patient has a diagnosis of Chronic Lymphocytic Leukemia
-
Patient is over the age of 18
-
Patient is being treated at a Duke Cancer Network affiliate site,
-
Patient is expected to see their physician or another member of their care team at least 3 times annually.
-
Signed informed consent
Exclusion Criteria: Clinician
- None
Exclusion Criteria: Patient
-
Patient is Non-English speaking
-
Patient diagnosed with CLL < 60 days ago
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Duke Cancer Network | Durham | North Carolina | United States |
Sponsors and Collaborators
- Duke University
- Med-IQ
- Gilead Sciences
- Genentech, Inc.
Investigators
- Principal Investigator: Linda Sutton, MD, Duke University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00063975